DWQA Questions › Tag: therapeutics
Filter:AllOpenResolvedClosedUnanswered
You have told us that re-infection with SARS-CoV-2 can cause a 10% incidence of cardiac problems, and things will worsen with each re-infection because of cumulative organ damage. Will the tissue injury be less during each bout of illness if people are vaccinated?
ClosedNicola asked 2 years ago • 
203 views0 answers0 votes
A practitioner writes: “Went on holidays with my wife and son to spend time with my lifelong friend who I have known since we were 2 years of age. We stayed at his house as it was his 50th Birthday. We were there for a week and on the second to last day, I developed a cough. I didn’t think it was COVID as my friend had a cough for a few weeks and he had tested himself several times and was negative. I performed two sessions while I was away and would pray for protection when out in public but not every time. We flew back home and I tested myself with a home kit and I was positive. I performed a couple of sessions for my friend’s family and those who I came in contact with, so far none of them have tested positive. I sneezed twice in the car when driving my son and wife home from the airport. Two days after the home test, I had a test at a clinic and tested positive again, and I was wondering why it would be positive after performing several sessions. Does the COVID test detect the virus or a side effect of the virus? I am in isolation and only have mild flu symptoms.” What can we tell him?
ClosedNicola asked 3 years ago • 
292 views0 answers0 votes
Have the careful scientific studies, which essentially show no effectiveness of facemask use to prevent transmission of respiratory virus infections like influenza and COVID-19, been interfered with to discourage rigorous use and add to fears, or are there methodological problems, like many of the masks in use, such as cloth masks and surgical masks, being poorly effective compared to KN95 grade face masks?
ClosedNicola asked 3 years ago • 
306 views0 answers0 votes
A long-term COVID-19 clinical trial of ivermectin as a therapeutic was just suspended. The reason given was there were supply chain issues, and because it wasn’t really expected to show promise, they were dropping the study. Some physicians have suspected an ulterior motive, as ivermectin is readily available worldwide as a generic drug and being used all around the world to treat COVID 19. They also pointed out that the study itself seemed designed to fail. It was only using a 3-day treatment with a low dose of ivermectin. In addition, it was including people anytime up to 14 days post-diagnosis, which they argue put the drug at a disadvantage because there would be patients with advanced illness, and ivermectin is in use, successfully, as an early-stage therapy. Is there something suspect here?
ClosedNicola asked 3 years ago • 
283 views0 answers0 votes